Home LiteratureArticle Details
PMID: 17569887 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling.

Circulation research ·Vol. 101 ·No. 3 ·2007-08-03 ·Pages 313-21

Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW, Conway SJ, Aronow BJ, Robbins J, Molkentin JD

Abstract

The cardiac extracellular matrix is a dynamic structural support network that is both influenced by, and a regulator of, pathological remodeling and hypertrophic growth. In response to pathologic insults, the adult heart reexpresses the secreted extracellular matrix protein periostin (Pn). Here we show that Pn is critically involved in regulating the cardiac hypertrophic response, interstitial fibrosis, and ventricular remodeling following long-term pressure overload stimulation and myocardial infarction. Mice lacking the gene encoding Pn (Postn) were more prone to ventricular rupture in the first 10 days after a myocardial infarction, but surviving mice showed less fibrosis and better ventricular performance. Pn(-/-) mice also showed less fibrosis and hypertrophy following long-term pressure overload, suggesting an intimate relationship between Pn and the regulation of cardiac remodeling. In contrast, inducible overexpression of Pn in the heart protected mice from rupture following myocardial infarction and induced spontaneous hypertrophy with aging. With respect to a mechanism underlying these alterations, Pn(-/-) hearts showed an altered molecular program in fibroblast function. Indeed, fibroblasts isolated from Pn(-/-) hearts were less effective in adherence to cardiac myocytes and were characterized by a dramatic alteration in global gene expression (7% of all genes). These are the first genetic data detailing the function of Pn in the adult heart as a regulator of cardiac remodeling and hypertrophy.

MeSH Terms
Aging/pathology Animals Cardiomegaly/etiology,physiopathology Cell Adhesion Cell Adhesion Molecules/deficiency,genetics,metabolism,physiology Cicatrix/etiology,pathology Collagen/metabolism Fibroblasts/metabolism,pathology Fibrosis Gene Expression Profiling Gene Expression Regulation Genetic Predisposition to Disease Granulocytes/pathology Heart Rupture/etiology Mice Mice, Knockout Mice, Transgenic Myocardial Infarction/complications,pathology Myocardium/metabolism Myocytes, Cardiac/pathology Pressure Recombinant Fusion Proteins/physiology Up-Regulation Ventricular Remodeling/physiology
Chemicals
Cell Adhesion Molecules Postn protein, mouse Recombinant Fusion Proteins Collagen
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Oka Toru
Department of Pediatrics, University of Cincinnati, Division of Molecular Cardiovascular Biology, Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Xu Jian
Kaiser Robert A
Melendez Jaime
Hambleton Michael
Sargent Michelle A
Lorts Angela
Brunskill Eric W
Dorn Gerald W
Conway Simon J
Aronow Bruce J
Robbins Jeffrey
Molkentin Jeffery D
References (40)
40 references, click to expand
  1. Periostin and periostin-like factor in the human heart: possible therapeutic targets.
    Cardiovasc Pathol. 2006 Jan-Feb;15(1):24-32 PMID: 16414453
  2. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype.
    Mol Cell Biol. 2005 Dec;25(24):11131-44 PMID: 16314533
  3. Periostin is an extracellular matrix protein required for eruption of incisors in mice.
    Biochem Biophys Res Commun. 2006 Apr 14;342(3):766-72 PMID: 16497272
  4. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.
    Circ Res. 2006 Mar 31;98(6):837-45 PMID: 16514068
  5. Integrin signalling: the tug-of-war in heart hypertrophy.
    Cardiovasc Res. 2006 Jun 1;70(3):422-33 PMID: 16466704
  6. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.
    J Allergy Clin Immunol. 2006 Jul;118(1):98-104 PMID: 16815144
  7. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation.
    J Biol Chem. 2006 Jul 14;281(28):19700-8 PMID: 16702213
  8. Cardiac fibroblasts: friend or foe?
    Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1015-26 PMID: 16617141
  9. Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.
    Atherosclerosis. 2006 Oct;188(2):292-300 PMID: 16325820
  10. Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophy.
    Circ Res. 2006 Sep 15;99(6):636-45 PMID: 16902179
  11. Fibroblasts modulate cardiomyocyte excitability: implications for cardiac gene therapy.
    Gene Ther. 2006 Nov;13(22):1611-5 PMID: 16838030
  12. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
    Circulation. 2006 Nov 21;114(21):2271-9 PMID: 17088456
  13. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase.
    Dev Biol. 2007 Feb 1;302(1):256-66 PMID: 17070513
  14. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.
    Oncogene. 2007 Mar 29;26(14):2082-94 PMID: 17043657
  15. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues.
    J Cell Biochem. 2007 Jun 1;101(3):695-711 PMID: 17226767
  16. Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling.
    Cardiovasc Res. 2006 Feb 15;69(3):574-84 PMID: 16253214
  17. Identification of genes regulated during mechanical load-induced cardiac hypertrophy.
    J Mol Cell Cardiol. 2000 May;32(5):805-15 PMID: 10775485
  18. Altered patterns of gene expression in response to myocardial infarction.
    Circ Res. 2000 May 12;86(9):939-45 PMID: 10807865
  19. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation.
    Mech Dev. 2001 May;103(1-2):183-8 PMID: 11335131
  20. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis.
    Circulation. 2001 Sep 18;104(12 Suppl 1):I308-I3 PMID: 11568074
  21. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.
    Cancer Res. 2002 Sep 15;62(18):5358-64 PMID: 12235007
  22. Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction.
    Circulation. 2002 Oct 22;106(17):2244-9 PMID: 12390955
  23. Long-term trends in the incidence of and survival with heart failure.
    N Engl J Med. 2002 Oct 31;347(18):1397-402 PMID: 12409541
  24. Lifetime risk for developing congestive heart failure: the Framingham Heart Study.
    Circulation. 2002 Dec 10;106(24):3068-72 PMID: 12473553
  25. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter.
    Circ Res. 2003 Apr 4;92(6):609-16 PMID: 12623879
  26. The divergent expression of periostin mRNA in the periodontal ligament during experimental tooth movement.
    Cell Tissue Res. 2003 Jun;312(3):345-51 PMID: 12761672
  27. Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse.
    Hypertension. 2003 Jul;42(1):88-95 PMID: 12756220
  28. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Circ Res. 2004 Jan 9;94(1):110-8 PMID: 14656927
  29. Periostin as a novel factor responsible for ventricular dilation.
    Circulation. 2004 Sep 28;110(13):1806-13 PMID: 15381649
  30. Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction.
    Am J Cardiol. 1987 Feb 1;59(4):363-4 PMID: 3812291
  31. Sequence analysis and neuronal expression of fasciclin I in grasshopper and Drosophila.
    Cell. 1988 May 20;53(4):577-87 PMID: 3370670
  32. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I.
    Biochem J. 1993 Aug 15;294 ( Pt 1):271-8 PMID: 8363580
  33. Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro.
    J Invest Dermatol. 1995 May;104(5):844-9 PMID: 7738366
  34. Expression and characterization of murine osteoblast-specific factor 2 (OSF-2) in a baculovirus expression system.
    Protein Expr Purif. 1995 Jun;6(3):305-11 PMID: 7663166
  35. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995.
    Am Heart J. 1999 Feb;137(2):352-60 PMID: 9924171
  36. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.
    J Bone Miner Res. 1999 Jul;14(7):1239-49 PMID: 10404027
  37. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice.
    Hypertension. 2004 Dec;44(6):826-31 PMID: 15534078
  38. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure.
    Annu Rev Pharmacol Toxicol. 2005;45:657-87 PMID: 15822192
  39. Matrix modulation and heart failure: new concepts question old beliefs.
    Curr Opin Cardiol. 2005 May;20(3):211-6 PMID: 15861009
  40. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo.
    J Biol Chem. 2005 Sep 23;280(38):32602-8 PMID: 16043490
Article Info
Journal
Circulation research
Abbr.
Circ Res
ISSN
1524-4571
Published
2007-08-03
Epub
2007-00-14
Pages
313-21
Language
English
Region
United States
NLM ID
0047103
PMCID
PMC2680305
Subset
IM
Grants
NHLBI NIH HHS · R01 HL081104-04 · United States
NHLBI NIH HHS · P01 HL069779-06A10003 · United States
NHLBI NIH HHS · P50 HL077101-050004 · United States
NHLBI NIH HHS · P01 HL069779 · United States
NHLBI NIH HHS · R01 HL062927 · United States
NHLBI NIH HHS · R01 HL060562-11 · United States
NHLBI NIH HHS · R01 HL062927-10A1 · United States
Howard Hughes Medical Institute · United States
NHLBI NIH HHS · R01 HL081104 · United States
NHLBI NIH HHS · R01 HL060562 · United States
NHLBI NIH HHS · P50 HL077101 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com